83 related articles for article (PubMed ID: 11003614)
21. Expression and activities of cyclins and cyclin-dependent kinases in developing rat ventricular myocytes.
Brooks G; Poolman RA; McGill CJ; Li JM
J Mol Cell Cardiol; 1997 Aug; 29(8):2261-71. PubMed ID: 9281457
[TBL] [Abstract][Full Text] [Related]
22. Intestinal cell cycle regulations. Interactions of cyclin D1, Cdk4, and p21Cip1.
Beauchamp RD; Sheng HM; Shao JY; Thompson EA; Ko TC
Ann Surg; 1996 May; 223(5):620-7; discussion 627-8. PubMed ID: 8651753
[TBL] [Abstract][Full Text] [Related]
23. Prevention of spontaneous hepatocellular carcinoma in Long-Evans cinnamon rats with hereditary hepatitis by the administration of D-penicillamine.
Jong-Hon K; Togashi Y; Kasai H; Hosokawa M; Takeichi N
Hepatology; 1993 Sep; 18(3):614-20. PubMed ID: 8395459
[TBL] [Abstract][Full Text] [Related]
24. Cell-cycle inhibition by TNP-470 in an in vivo model of hepatocarcinoma is mediated by a p53 and p21WAF1/CIP1 mechanism.
Mauriz JL; Gonzalez P; Duran MC; Molpeceres V; Culebras JM; Gonzalez-Gallego J
Transl Res; 2007 Jan; 149(1):46-53. PubMed ID: 17196522
[TBL] [Abstract][Full Text] [Related]
25. Cyclins: relevance of subcellular localization in cell cycle control.
Prosperi E; Stivala LA; Scovassi AI; Bianchi L
Eur J Histochem; 1997; 41(3):161-8. PubMed ID: 9359027
[No Abstract] [Full Text] [Related]
26. [Cyclin protein expression on malignant glioma cells].
Numa Y; Tsukazaki Y; Yamamoto M; Matsudaira T; Kawamoto K
Hum Cell; 1998 Mar; 11(1):21-6. PubMed ID: 9710717
[TBL] [Abstract][Full Text] [Related]
27. [MR images of the hepatocellular carcinoma in Long-Evans cinnamon (LEC) rats].
Nakakoshi T; Fujita N; Jong-Hon K; Takeichi N
Nihon Igaku Hoshasen Gakkai Zasshi; 1993 Dec; 53(12):1465-7. PubMed ID: 8108251
[TBL] [Abstract][Full Text] [Related]
28. Reciprocal expressions of cyclin E and cyclin D1 in hepatocellular carcinoma.
Jung YJ; Lee KH; Choi DW; Han CJ; Jeong SH; Kim KC; Oh JW; Park TK; Kim CM
Cancer Lett; 2001 Jul; 168(1):57-63. PubMed ID: 11368878
[TBL] [Abstract][Full Text] [Related]
29. Expression of cyclin H in normal and cancerous endometrium, its correlation with other cyclins, and association with clinicopathologic parameters.
Kayaselcuk F; Erkanli S; Bolat F; Seydaoglu G; Kuscu E; Demirhan B
Int J Gynecol Cancer; 2006; 16(1):402-8. PubMed ID: 16445666
[TBL] [Abstract][Full Text] [Related]
30. Immune response to cyclin B1 in hepatocellular carcinoma.
Covini G; Chan EK; Nishioka M; Morshed SA; Reed SI; Tan EM
Hepatology; 1997 Jan; 25(1):75-80. PubMed ID: 8985268
[TBL] [Abstract][Full Text] [Related]
31. Liver regeneration, liver cancers and cyclins.
Kitamura T; Watanabe S; Sato N
J Gastroenterol Hepatol; 1998 Sep; 13 Suppl():S96-9. PubMed ID: 9792041
[TBL] [Abstract][Full Text] [Related]
32. Involvement of cyclin D activity in left ventricle hypertrophy in vivo and in vitro.
Busk PK; Bartkova J; Strøm CC; Wulf-Andersen L; Hinrichsen R; Christoffersen TE; Latella L; Bartek J; Haunsø S; Sheikh SP
Cardiovasc Res; 2002 Oct; 56(1):64-75. PubMed ID: 12237167
[TBL] [Abstract][Full Text] [Related]
33. A possible novel src-related tyrosine kinase in cancer cells of LEC rats that develop hepatocellular carcinoma.
Masaki T; Tokuda M; Shiratori Y; Shirai M; Matsumoto K; Nishioka M; Omata M
J Hepatol; 2000 Jan; 32(1):92-9. PubMed ID: 10673072
[TBL] [Abstract][Full Text] [Related]
34. Diethylnitrosamine (DEN) induces irreversible hepatocellular carcinogenesis through overexpression of G1/S-phase regulatory proteins in rat.
Park DH; Shin JW; Park SK; Seo JN; Li L; Jang JJ; Lee MJ
Toxicol Lett; 2009 Dec; 191(2-3):321-6. PubMed ID: 19822196
[TBL] [Abstract][Full Text] [Related]
35. Overexpression of cyclin E and cyclin-dependent kinase 2 is correlated with development of hepatocellular carcinomas.
Kohzato N; Dong Y; Sui L; Masaki T; Nagahata S; Nishioka M; Konishi R; Tokuda M
Hepatol Res; 2001 Sep; 21(1):27-39. PubMed ID: 11470626
[TBL] [Abstract][Full Text] [Related]
36. Discordant expression of the cyclin-dependent kinases and cyclins in rat liver following acute administration of the hepatocarcinogen [4-chloro-6-(2,3-xylidino)-2-pyrimidinylthio] acetic acid (WY14,643).
Rininger JA; Wheelock GD; Ma X; Babish JG
Biochem Pharmacol; 1996 Dec; 52(11):1749-55. PubMed ID: 8986138
[TBL] [Abstract][Full Text] [Related]
37. Expression of p33(ING1) in hepatocellular carcinoma: relationships to tumour differentiation and cyclin E kinase activity.
Ohgi T; Masaki T; Nakai S; Morishita A; Yukimasa S; Nagai M; Miyauchi Y; Funaki T; Kurokohchi K; Watanabe S; Kuriyama S
Scand J Gastroenterol; 2002 Dec; 37(12):1440-8. PubMed ID: 12523595
[TBL] [Abstract][Full Text] [Related]
38. Identification of prognosis-related cyclin-dependent kinases and potential response drugs in hepatocellular carcinoma.
Chen S; Shen B; Wu Y; Shen L; Qi H; Cao F; Huang T; Tan H; Zhang G; Fan W
J Cancer Res Ther; 2023 Feb; 19(1):108-116. PubMed ID: 37006050
[TBL] [Abstract][Full Text] [Related]
39. Lack of intestinal bile results in delayed liver regeneration of normal rat liver after hepatectomy accompanied by impaired cyclin E-associated kinase activity.
Ueda J; Chijiiwa K; Nakano K; Zhao G; Tanaka M
Surgery; 2002 May; 131(5):564-73. PubMed ID: 12019411
[TBL] [Abstract][Full Text] [Related]
40. [Differential expression of cyclins D1, E and A in human breast diseases].
Ma L; Yin H; Yang W; Yang G; Lü Q; Liu X
Hua Xi Yi Ke Da Xue Xue Bao; 2001 Dec; 32(4):497-500. PubMed ID: 12528530
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
